Amalgamated Bank Sells 225 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Amalgamated Bank cut its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 1.5% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 14,873 shares of the biotechnology company’s stock after selling 225 shares during the quarter. Amalgamated Bank’s holdings in Axon Enterprise were worth $8,839,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. New Wave Wealth Advisors LLC bought a new position in shares of Axon Enterprise during the fourth quarter valued at $40,000. Y.D. More Investments Ltd acquired a new stake in shares of Axon Enterprise in the fourth quarter valued at $45,000. Prestige Wealth Management Group LLC increased its stake in shares of Axon Enterprise by 115.8% in the third quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock valued at $33,000 after buying an additional 44 shares in the last quarter. Stonebridge Financial Group LLC acquired a new stake in shares of Axon Enterprise in the fourth quarter valued at $53,000. Finally, GPS Wealth Strategies Group LLC increased its stake in shares of Axon Enterprise by 74.1% in the fourth quarter. GPS Wealth Strategies Group LLC now owns 94 shares of the biotechnology company’s stock valued at $56,000 after buying an additional 40 shares in the last quarter. 79.08% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of brokerages have recently weighed in on AXON. Northcoast Research lowered Axon Enterprise from a “buy” rating to a “neutral” rating in a research note on Wednesday, February 19th. Craig Hallum lowered Axon Enterprise from a “buy” rating to a “hold” rating and set a $625.00 target price for the company. in a research note on Thursday, February 20th. Morgan Stanley upgraded Axon Enterprise from an “equal weight” rating to an “overweight” rating and raised their target price for the company from $500.00 to $700.00 in a research note on Tuesday, December 3rd. JMP Securities restated an “outperform” rating on shares of Axon Enterprise in a research note on Tuesday, February 4th. Finally, Robert W. Baird lifted their price objective on Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a research report on Friday, December 6th. Three analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $561.31.

Axon Enterprise Price Performance

Shares of AXON opened at $496.65 on Wednesday. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a 1 year low of $265.32 and a 1 year high of $715.99. The stock has a market cap of $37.87 billion, a P/E ratio of 128.33, a price-to-earnings-growth ratio of 5.17 and a beta of 1.05. The stock’s 50-day moving average price is $614.17 and its two-hundred day moving average price is $521.71.

Insider Activity

In other news, Director Caitlin Elizabeth Kalinowski sold 450 shares of Axon Enterprise stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total transaction of $271,831.50. Following the transaction, the director now owns 6,929 shares in the company, valued at $4,185,601.03. The trade was a 6.10 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, President Joshua Isner sold 1,291 shares of Axon Enterprise stock in a transaction dated Tuesday, December 17th. The shares were sold at an average price of $642.43, for a total value of $829,377.13. Following the transaction, the president now owns 181,892 shares in the company, valued at $116,852,877.56. This trade represents a 0.70 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 8,711 shares of company stock worth $5,631,561 in the last 90 days. Corporate insiders own 5.70% of the company’s stock.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.